← Back to Search

Behavioural Intervention

Binocular Peripheral Myopic Defocus Using a Clinical Prototype Device

N/A
Waitlist Available
Led By Arkady Selenow, OD
Research Sponsored by Kubota Vision Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new pair of glasses that use light therapy to slow down worsening nearsightedness in people with myopia. The glasses aim to control eye growth over a period of time.

Eligible Conditions
  • Near-sightedness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Group II: CP1 deviceActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Kubota Vision Inc.Lead Sponsor
19 Previous Clinical Trials
2,176 Total Patients Enrolled
Arkady Selenow, ODPrincipal InvestigatorManhattan Vision Associates/Institute of Vision Research
2 Previous Clinical Trials
38 Total Patients Enrolled
~13 spots leftby Dec 2025